The released Kyn induced the expression of CCR2 by activating AHR, and advanced the recruitment of macrophages to tumor sites by enhancing the response to MCP-1 secreted by glioma cells (Takenaka et al., 2019). The gene discussed is CCR2; the disease is central nervous system cancer.